Product Information
DARUNAVIR 600 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $1.1628 per EA under NDC 68180034507. Its NADAC has been published 137 times since Feb 21, 2024.
FDA first approved this application on Sep 29, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
600 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180034507
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DARUNAVIR ETHANOLATEApproval Type
Generic (ANDA)
FDA Application
ANDA202073FDA Approved
9/29/2022
TE Code
AB
On Market Since
6/1/2023
Pharmacological Classes
Price Statistics
The NADAC for DARUNAVIR 600 MG TABLET has been published 137 times since Feb 21, 2024, and over the history we have for it it has declined 69.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1628 per EA |
|---|---|
| All-time high | $3.7496 (Mar 13, 2024) |
| All-time low | $1.1309 (Mar 18, 2026) |
| 52-week high | $1.2126 |
| 52-week low | $1.1309 |
| Median price | $1.3072 |
| Average price | $1.4232 |
| Largest weekly change | -51.1% (Mar 20, 2024) |
| Weeks tracked | 137 |
| Tracking since | Feb 21, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the DARUNAVIR market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DARUNAVIR market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Protease Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DARUNAVIR 600 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DARUNAVIR 600 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $1.1628 per EA (NDC 68180034507), effective Sep 30, 2026.
How has the price of DARUNAVIR 600 MG TABLET changed over time?
Over the history we have for it, the NADAC for DARUNAVIR 600 MG TABLET has declined 69.0%. It has been tracked across 137 weekly CMS publications since Feb 21, 2024.
What are the highest and lowest recorded NADAC prices for DARUNAVIR 600 MG TABLET?
Since Feb 21, 2024, the NADAC for DARUNAVIR 600 MG TABLET has ranged from a low of $1.1309 (Mar 18, 2026) to a high of $3.7496 (Mar 13, 2024), with a median of $1.3072 per EA.
Are there cheaper alternatives to DARUNAVIR 600 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of DARUNAVIR 600 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DARUNAVIR 600 MG TABLET?
DARUNAVIR 600 MG TABLET (NDC 68180034507) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.